Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Holdings

2,389.08
+22.540.95%
Number of Gainers:68
Number of Losers:26
Number of Flat:3
PE:- -
High:2,396.41
Open:2,366.62
Low:2,366.55
Close:2,366.54
Volume:1.30B
Turnover:281.48B
Market Cap:52.92T
Float Cap:49.57T

Loading ...

Xetra Closing Stock Prices

Dow Jones
·
Sep 24

E-Pango Shares Microsoft Teams Link for Shareholder Webinar

Reuters
·
Sep 24

Experian Integrates Personal Finance App with Google Gemini AI Platform

Reuters
·
Sep 24

The ASX’s highest-yielding dividend stocks

Commsec
·
Sep 24

Verizon Stock (VZ) Climbs as It Unveils $70M Plan to Make Americans AI-Ready

TIPRANKS
·
Sep 23

Update: Market Chatter: Anthropic, OpenEvidence Team Up to Expand Medical AI Globally

MT Newswires Live
·
Sep 23

McDonald’s expects U.S. comps to be ‘slightly negative’ for Q3

TIPRANKS
·
Sep 23

YouTube to Introduce New Tools for Digital Producers as it Competes with Netflix for Talent

Dow Jones
·
Sep 23

Google: Introducing Two New Text-to-Speech Models to Gemini Family, Gemini 3.8 Flash Tts & Gemini 3.8 Flash-Lite Tts - Blog

THOMSON REUTERS
·
Sep 23

Union Pacific Deploys First Two Wabtec FLXdrive Battery-Electric Locomotives in Southern California

Reuters
·
Sep 23

Microsoft Stock Wins Upgrade. Why This Analyst Sees 15% Upside.

Dow Jones
·
Sep 23

McDonald's Shares Tumble Nearly 5% as US Sales Weakness Clouds Major Investor Event

Stock News
·
Sep 23

McDonald's Shares Extend Losses, Last Down 5.2%

THOMSON REUTERS
·
Sep 23

Alphabet's YouTube Announces New Features, Updates at Annual Event

MT Newswires Live
·
Sep 23

Cboe data suggests bullish flow in ServiceNow with shares up 1.33%

TIPRANKS
·
Sep 23

McDonald’s sees net new unit growth of about 4.5% in 2027

TIPRANKS
·
Sep 23

Palantir, IonQ, Royal Caribbean, Paychex, McDonald's, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 23

Disney Stock (DIS) Rises on Plan to Increase Streaming Prices

TIPRANKS
·
Sep 23

Qinghai Biotech Pharmaceutical Rebrands with New Name and Stock Short Name

TIPRANKS
·
Sep 23

Johnson & Johnson Says New Analysis of Ongoing Phase 3 Trial Data Supports Potential of Multiple Myeloma Combination Therapy

MT Newswires Live
·
Sep 23